Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)

  • Stefania Aiello
  • , Geoffrey Wells
  • , Erica L. Stone
  • , Hachemi Kadri
  • , Rana Bazzi
  • , David R. Bell
  • , Malcolm F.G. Stevens
  • , Charles S. Matthews
  • , Tracey D. Bradshaw
  • , Andrew D. Westwell

    Research output: Contribution to journalArticlepeer-review

    Abstract

    New fluorinated 2-aryl-benzothiazoles, -benzoxazoles, and -chromen-4-ones have been synthesized and their activity against MCF-7 and MDA 468 breast cancer cell lines compared with the potent antitumor benzothiazole 5. Analogues such as 9a,b and 12a,d yielded submicromolar GI50 values in both cell lines; however, none of the new compounds approached 5 in terms of antitumor potency. For 5, binding to the aryl hydrocarbon receptor appeared to be necessary but not sufficient for growth inhibition.
    Original languageEnglish
    Pages (from-to)5135-5139
    JournalJournal of Medicinal Chemistry
    Volume51
    Issue number16
    Early online date31 Jul 2008
    DOIs
    Publication statusPublished - 28 Aug 2008

    Keywords

    • Cancer studies

    Fingerprint

    Dive into the research topics of 'Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)'. Together they form a unique fingerprint.

    Cite this